About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials | 16,743 Studies Recruiting

Clinical TrialsBreast Cancer

Breast Cancer Clinical Trials

Browse 16,743 clinical trials for breast cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2981-3000 of 16,743 trials

CompletedA Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersAn open-label, dose escalation and expansion clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors, metastatic…NCT03251378·Phoenix, Arizona and 8 others UnknownBreast Mesh Used in Two-staged Breast ReconstructionThis is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction.NCT04967976·Houston, Texas and 5 others RecruitingIncreasing Oral Medication Adherence for Metastatic Breast Cancer PatientsAim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate…NCT06726889·Milan

Related Searches

breast carcinomatrials

Data from ClinicalTrials.govTerms

CompletedBC-DAISY: A Breast Cancer Decision Aid SystemThe purpose of this study is to develop a web-based decision aid to help women at high risk for breast cancer make informed breast cancer prevention choices.NCT00347568·Providence, Rhode Island

RecruitingEvaluation and Outcomes of SAVI Scout MD for Localized Breast SurgeryThe purpose of the study is to evaluate how precise the SAVI Scout MD is and how easy it is for surgeons to use during surgery.NCT07686250·Tampa, Florida

UnknownThe Role of Calcipotriol as Radioprotector of SkinExamining the hypothesis that protecting keratinocytes by calcipotriol can prevent in-vivo cutaneous side effect in patients receiving radiotherapy to the breast.NCT00445250·Petach Tiqva

CompletedSymptoms Experienced and Quality of Life in Breast Cancer Receiving RadiotherapyEORTC-QLQ-30 questionnaire filled in by participants 6 timesNCT03106350

CompletedCost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.The purpose of this study is to analyze the average direct costs of each of these techniques, represented by the costs directly linked to the management of breast cancer, to the…NCT05699291·Paris

CompletedCombination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy such as cyclophosphamide, methotrexate, and fluorouracil use different ways to stop tumor cells from dividing so they stop growing or die.NCT00036868·Antwerp and 12 others

Enrolling by invitationReal-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer SurgeryThis study aims to explore the clinical efficacy of Shenbailing granules in improving quality of life and reducing cancer-related fatigue in a real-world setting, with the goal of…NCT06881550·Shenyang, Chian/Liaoning

CompletedStudy to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast CancerThis is a Phase 2, open-label, single arm, multicenter, 2-stage study of eribulin mesylate administered biweekly at 1.4 mg/m2 intravenously for the treatment of participants with…NCT02481050·Denver, Colorado and 11 others

UnknownArtificial Intelligence for breaST canceR scrEening in mAMmography (AI-STREAM)This prospective study aims to generate real-world evidence on the overall benefits and disadvantages of using Lunit INSIGHT MMG AI based CADe/x for breast cancer detection in a…NCT05024591·Seongnam-si and 4 others

TerminatedAssessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR)Consecutive patients with a first diagnosis of breast cancer will be identified at the Tom Baker Cancer Centre (TBCC) and included into the study, if they are going to receive…NCT00679874·Calgary, Alberta

Active not recruitingNIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast CancerThis research study is studying a drug combination of nivolumab and ipilimumab as a possible treatment for hypermutated HER2 negative breast cancer.NCT03789110·Boston, Massachusetts and 2 others

TerminatedBemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBCThis is an open label, single arm, multi-centre phase II study to assess the anti-tumour activity and safety of bemcentinib (BGB324) in combination with pembrolizumab in…NCT03184558·Duarte, California and 16 others

Active not recruitingImmune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast CancerThis phase I trial studies the side effects and best dose of M5A-IL2 immunocytokine (M5A-ICK) combined with stereotactic body radiation therapy (SBRT) and to see how well they…NCT06130826·Duarte, California

RecruitingPre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IOTo determine whether short-term pre-operative nivolumab either as monotherapy or in combination with low dose doxorubicin or novel IO combinations can induce immune activation in…NCT03815890·Amsterdam

Not yet recruitingEvaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.Breast cancer, the most common cancer in women, is increasingly managed as a chronic disease thanks to therapeutic advances.NCT07425548

TerminatedA Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer GrowthThis study is investigating the effects of a new hormone treatment for breast cancer called Irosustat.NCT01662726·London, London

CompletedStudying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast CancerRATIONALE: Studying samples of nipple fluid, urine, and blood in the laboratory from patients with cancer and from patients at risk of developing cancer may help doctors identify…NCT00897208·Rochester, Minnesota

PreviousPage 150 of 838Next